Adolescents with overweight or obesity and asthma taking a GLP-1 agent had less risk of asthma exacerbations compared with ...

GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on ...

In response to ‘Mad About Science’ By Jim McCabeReader Contributor I cringed at Brenden Bobby’s “Mad about Science” column on ...

New research reveals how GLP-1 medications are reshaping the treatment landscape for conditions affecting the heart, kidney, liver, and more, hinting at a new era in chronic disease management.

Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...

Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...

The uptake of GLP-1 drugs is extraordinary. Everyone is either taking them, considering taking them, or knows someone else who has. And it’s this speed of adoption that’s powered the global market to ...